Tempus
PROVIDERS
LIFE SCIENCES
PATIENTS
OUR PLATFORM
ORDER A TEST
Log In
Contact Us
Menu
Tempus
ORDER A TEST
Log In
Contact Us
Providers
Oncology
Neurology & Psychiatry
Infectious Disease
Cardiology
Academic & Research
EMR Integration
Life Sciences
Sequencing
Companion Diagnostics
Clinical Trial Solutions
Data Collaborations
AI Applications
Biological Modeling
Patients
Oncology Patients
Neurology Patients
Infectious Disease Patients
Our Platform
Genomic Profiling
Clinical Trial Matching
Companion Diagnostics
Multi-Omics
Tempus ONE
Infectious Disease
About Us
Our Team
Careers
Culture
Resources
Publications
News
Blog
Resources
Publications
Keyword search
Filter By
Oncology
Infectious Disease
Cardiology
Neuro/Psych
05/26/2022
Oncology
Real World Data To Enable Large-Scale Assessment of WHO CNS5 Glioma Classification
05/26/2022
Oncology
Comparative Analysis of Microsatellite Instability-High (MSI-H) BRAF V600E–Mutated Versus MSI-H BRAFwild Type Colorectal Cancers (CRC), Including Tumor Microenvironment (TME), Associated Genomic Alterations, and Immuno-Metabolomic Biomarkers
05/26/2022
Oncology
Natural Language Processing-Optimized Case Selection for Real World Evidence Studies
05/26/2022
Oncology
Genetic Ancestry Correlates of the Cancer Somatic Mutational Landscape From Tumor Profiling Data of 50,000 Cancer Patients
05/26/2022
Oncology
Use Of Clinical RNA-Sequencing In the Detection of Actionable Fusions Compared To DNA-Sequencing Alone
05/26/2022
Oncology
Impact of RAS Mutations on Immunologic Characteristics of the Tumor Microenvironment (TME) In Patients With Microsatellite Instability-High (MSI-H) or Mismatch-Repair–Deficient (dMMR) Colorectal Cancer (CRC)
05/26/2022
Oncology
Prevalence of High Tumor Mutational Burden (TMB-H) and Microsatellite Instability-High (MSI-H) Status in Neuroendocrine Neoplasms
05/26/2022
Oncology
Genomic Landscape of SMARCA4-Deficient Lung Tumors by Clinical RNA Sequencing
05/26/2022
Oncology
Dual Tissue and Plasma Testing Improves Detection of Actionable Variants in Patients With Solid Cancers
05/23/2022
Oncology
Multi-institutional Study of the Frequency, Genomic Landscape, and Outcome of IDH-Mutant Glioma in Pediatrics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21